Correlation Between Phibro Animal and EuropaCorp

Can any of the company-specific risk be diversified away by investing in both Phibro Animal and EuropaCorp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phibro Animal and EuropaCorp into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Phibro Animal Health and EuropaCorp, you can compare the effects of market volatilities on Phibro Animal and EuropaCorp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phibro Animal with a short position of EuropaCorp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phibro Animal and EuropaCorp.

Diversification Opportunities for Phibro Animal and EuropaCorp

-0.49

Correlation Coefficient

Phibro Animal  EuropaCorp

Very good diversification

The 3 months correlation between Phibro and EuropaCorp is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Phibro Animal Health and EuropaCorp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EuropaCorp and Phibro Animal is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phibro Animal Health are associated (or correlated) with EuropaCorp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EuropaCorp has no effect on the direction of Phibro Animal i.e., Phibro Animal and EuropaCorp go up and down completely randomly.

Pair Corralation between Phibro Animal and EuropaCorp

Assuming the 90 days horizon Phibro Animal Health is expected to generate 0.68 times more return on investment than EuropaCorp. However, Phibro Animal Health is 1.47 times less risky than EuropaCorp. It trades about 0.05 of its potential returns per unit of risk. EuropaCorp is currently generating about 0.0 per unit of risk. If you would invest  1,242  in Phibro Animal Health on October 8, 2024 and sell it today you would earn a total of  758.00  from holding Phibro Animal Health or generate 61.03% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Phibro Animal Health  vs.  EuropaCorp

Phibro Animal Health

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Phibro Animal Health are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Phibro Animal may actually be approaching a critical reversion point that can send shares even higher in February 2025.

EuropaCorp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days EuropaCorp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Phibro Animal and EuropaCorp

The main advantage of trading using opposite Phibro Animal and EuropaCorp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phibro Animal position performs unexpectedly, EuropaCorp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EuropaCorp will offset losses from the drop in EuropaCorp's long position.

The idea behind Phibro Animal Health and EuropaCorp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.